Relay Therapeutics (RLAY)
US Market

Relay Therapeutics (RLAY) Stock Price & Analysis


RLAY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$12.65 - $35.36
Previous Close$15.31
Average Volume (3M)1.28M
Market Cap
Enterprise Value$917.23M
Total Cash (Recent Filing)$998.92M
Total Debt (Recent Filing)$57.74M
Price to Earnings (P/E)-5.9
May 04, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.60
Shares Outstanding120,894,901
10 Day Avg. Volume1,003,465
30 Day Avg. Volume1,277,732
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)2.23
Price to Sales (P/S)1977.40
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-12.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue664.17
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.99
Price Target Upside140.76% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7




What was Relay Therapeutics’s price range in the past 12 months?
Relay Therapeutics lowest stock price was $12.65 and its highest was $35.36 in the past 12 months.
    What is Relay Therapeutics’s market cap?
    Currently, no data Available
    When is Relay Therapeutics’s upcoming earnings report date?
    Relay Therapeutics’s upcoming earnings report date is May 04, 2023 which is in 39 days.
      How were Relay Therapeutics’s earnings last quarter?
      Relay Therapeutics released its earnings results on Feb 23, 2023. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.702 by $0.142.
        Is Relay Therapeutics overvalued?
        According to Wall Street analysts Relay Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Relay Therapeutics pay dividends?
          Relay Therapeutics does not currently pay dividends.
          What is Relay Therapeutics’s EPS estimate?
          Relay Therapeutics’s EPS estimate is -$0.7.
            How many shares outstanding does Relay Therapeutics have?
            Relay Therapeutics has 121,384,720 shares outstanding.
              What happened to Relay Therapeutics’s price movement after its last earnings report?
              Relay Therapeutics reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.702. Following the earnings report the stock price went down -2.123%.
                Which hedge fund is a major shareholder of Relay Therapeutics?
                Among the largest hedge funds holding Relay Therapeutics’s share is Perceptive Advisors LLC. It holds Relay Therapeutics’s shares valued at 29M.


                  Relay Therapeutics Stock Smart Score

                  The Relay Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Relay Therapeutics

                  Relay Therapeutics Inc is a precision medicines company focused on enhancing small molecule therapeutic discovery in targeted oncology. Its pipeline products include RLY-1971 and RLY-4008 and among others.


                  Top 5 ETFs holding RLAY

                  Market Value
                  Smart Score
                  Fidelity Nasdaq Composite Index ETF
                  Vanguard ESG U.S. Stock ETF
                  Invesco Nasdaq Biotechnology ETF
                  BMO MSCI Innovation Index ETF
                  V-Shares US Leadership Diversity ETF
                  Up to five ETFs with an Outperform Smart Score that hold RLAY. The ETFs are listed according to market value of RLAY within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  ACADIA Pharmaceuticals
                  SAGE Therapeutics
                  Arcus Biosciences

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis